Relevance of genetic disposition versus environmental exposure for cancer risk: An old controversy revisited with novel methods

EXCLI Journal

Volumn 12, Issue , 2013, Pages 79-80

  Bolt, H M ^a  

^a TU DORTMUND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE; POLYCYCLIC AROMATIC HYDROCARBON;

BLADDER CANCER; CANCER RISK; EDITORIAL; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; OCCUPATIONAL EXPOSURE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 84873377742     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Binder H, Müller T, Schwender H, Golka K, Steffens M, Hengstler JG et al. Clusterlocalized sparse logistic regression for SNP data. Stat Appl Gen Mol Biol 2012;11(4): article 13.
2. Golka K, Hermes M, Selinski S, Blaszkewicz M, Bolt HM, Roth G et al. Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure. Pharmacogen Genom 2009;19:903-6.
3. Golka K, Selinski S, Lehmann ML, Blaszkewicz M, Marchan R, Ickstadt K et al. Genetic variants in urinary bladder cancer: collective power of the wimp SNPs. Arch Toxicol 2011;85:539-54.
4. Golka K, Kopps S, Prager HM, MENDE SV, Thiel R, Jungmann O et al. Bladder cancer in crack testers applying azo dye-based sprays to metal bodies. J Toxicol Environ Health 2012a;75A:566-71.
5. Golka K, Abreu-Villaca Y, Anbari Attar R, Angeli-Greaves M, Aslam M, Basaran N et al. Bladder cancer documentation of causes: multilingual questionnaire, 'bladder cancer doc'. Front Biosci (Elite Ed) 2012b;4:2809-22.
6. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008;40: 1307-12.
7. Kiemeney LA, Sulem P, Besenbacher S, Vermeulen SH, Sigurdsson A, Thorleifsson G et al. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet 2010;42:415-9.
8. Lehmann ML, Selinski S, Blaszkewicz M, Orlich M, Ovsiannikov D, Moormann O et al. Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk. Arch Toxicol 2010;84:967-78.
9. Ovsiannikov D, Selinski S, Lehmann ML, Blaszkewicz M, Moormann O, Haenel MW et al. Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry. J Toxicol Environ Health 2012;75A:557-65.
10. Rafnar T, Vermeulen SH, Sulem P, Thorleifsson G, Aben KK, Witjes JA et al. European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet 2011;20:4268-81.
11. Roth E, Selinski S, Schikowsky C, Seidel T, Volkert F, Blaszkewicz M et al. Bladder cancer survival in a former industrial area in Saxony-Anhalt, Germany. J Toxicol Environ Health 2012;75A:1216-25.
12. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010;42:978-84.
13. Schwender H, Selinski S, Blaszkewicz M, Marchan R, Ickstadt K, Golka K et al. Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers. PLoS One 2012; 7(12): 51880.
14. Selinski S, Lehmann ML, Blaszkewicz M, Ovsiannikov D, Moormann O, Guballa C et al. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk. Arch Toxicol 2012a Sep;86:1369-78.
15. Selinski S, Lehmann ML, Blaszkewicz M, Ovsiannikov D, Moormann O, Guballa C et al. Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene. Arch Toxicol 2012b;86:195-203.